{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:54:16Z","timestamp":1783385656291,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T11:39:38Z","timestamp":1547552378000},"page":"300-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal"],"prefix":"10.1016","volume":"17","author":[{"given":"Bruno","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-0088","authenticated-orcid":false,"given":"Maria Manuel","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Luxo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Martinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.01.008_bib0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgar.2019.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2019.01.008_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/hel.12061","article-title":"Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults","volume":"18","author":"Bastos","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2019.01.008_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2019.01.008_bib0025","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"Lofmark","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/AAC.01449-08","article-title":"A redox basis for metronidazole resistance in Helicobacter pylori","volume":"53","author":"Kaakoush","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.008_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182017002025","article-title":"A review on metronidazole: an old warhorse in antimicrobial chemotherapy","volume":"23","author":"Leitsch","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.jgar.2019.01.008_bib0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/1469-0691.12701","article-title":"Helicobacter pylori antimicrobial resistance rates in the central region of Portugal","volume":"20","author":"Almeida","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.01.008_bib0045","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.44.8.2133-2142.2000","article-title":"Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori","volume":"44","author":"Kwon","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.008_bib0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1083-4389.2004.00270.x","article-title":"The rdxA gene plays a more major role than frxA gene mutation in high-level metronidazole resistance of Helicobacter pylori in Taiwan","volume":"9","author":"Yang","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2019.01.008_bib0055","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2016"},{"key":"10.1016\/j.jgar.2019.01.008_bib0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jgar.2019.01.008_bib0065","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1128\/JB.182.18.5082-5090.2000","article-title":"Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori","volume":"182","author":"Jeong","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2019.01.008_bib0070","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/AAC.44.8.2207-2210.2000","article-title":"Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains","volume":"44","author":"Solc\u00e0","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.008_bib0075","article-title":"Analysis of allelic variants of rdxA associated with metronidazole resistance in Helicobacter pylori: detection of common genotypes in rdxA by multiplex allele-specific polymerase chain reaction","volume":"15","author":"Bultop","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jgar.2019.01.008_bib0080","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1111\/febs.12020","article-title":"Structure of RdxA\u2014an oxygen-insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori","volume":"279","author":"Mart\u00ednez-J\u00falvez","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.jgar.2019.01.008_bib0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ja.2008.6","article-title":"Genetic analysis of Helicobacter pylori clinical isolates suggests resistance to metronidazole can occur without the loss of functional rdxA","volume":"62","author":"Kim","year":"2009","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jgar.2019.01.008_bib0090","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/AAC.49.3.1236-1237.2005","article-title":"Mutational analysis of metronidazole resistance in Helicobacter pylori","volume":"49","author":"Moore","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.008_bib0095","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1111\/febs.12958","article-title":"FrxA is an S-nitrosoglutathione reductase enzyme that contributes to Helicobacter pylori pathogenicity","volume":"281","author":"Justino","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.jgar.2019.01.008_bib0100","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.04852-14","article-title":"Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing","volume":"59","author":"Binh","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.008_bib0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbrc.2010.12.034","article-title":"Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori","volume":"404","author":"Tsugawa","year":"2011","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:47:20Z","timestamp":1560876440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":21,"alternative-id":["S2213716519300153"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}